ThyroSafe 65mg Potassium Iodide Tablets
The essential FDA-approved thyroid protection for institutional stockpiles and family preparedness. This 65mg tablet offers precise dosing for children and teens, ensuring rapid deployment and effective defense against radioactive iodine during nuclear emergencies.
Additional Product Information
- Powerful Protection – Serves as a crucial line of defense in a nuclear emergency, saturating the thyroid with stable iodine to block the absorption of dangerous radioactive iodine.
- FDA-Approved – Manufactured as a trusted, FDA-approved source of thyroid protection using USP grade potassium iodide, ensuring compliance for government and institutional contracts.
- Simple to Use – Provides the precise, single-tablet dose recommended by the FDA for children and most teens (ages 3-18), eliminating the need to split larger tablets during mass distribution scenarios.
- Fast Administration – Tablets are ready for immediate ingestion and can be crushed and mixed into liquids for small children, simplifying administration for families and aid workers in high-stress environments.
- Long Lasting – Features a shelf life of up to 10 years, ensuring stockpiles remain effective for a decade and reducing the frequency of inventory turnover.
- Lightweight – The compact 20-tablet package weighs just 0.035 lbs, maximizing logistics efficiency for bulk transport or individual kit inclusion.
- Portable – Each tablet is individually sealed in foil to ensure stability and protection from light and moisture, maintaining high purity and potency in varying storage conditions.
- Flexible Dosing – While optimized for youth, adults can take two tablets to reach the required 130mg dose, making it a versatile single-SKU solution.
ThyroSafe 65mg Potassium Iodide Tablets are the professional standard for radiation emergency preparedness, designed to bridge the gap between institutional stockpile requirements and family safety. In the critical moments following a nuclear incident, preventing the thyroid from absorbing radioactive iodine is paramount. ThyroSafe provides this essential blockade using FDA-approved, USP-grade potassium iodide. This specific 65mg formulation is engineered to simplify mass distribution and administration; it provides the exact single-tablet dose recommended for children and teenagers (ages 3–18), eliminating the confusion and time lost trying to split adult-sized tablets during a crisis.
For government agencies, NGOs, and distributors, ThyroSafe offers unmatched logistical convenience. The tablets are individually foil-sealed for durability and boast a 10-year shelf life, making them a cost-effective, low-maintenance solution for long-term caches and emergency supplies. The versatility of the tablet extends its utility across entire populations: while perfect for youth, adults can simply take two tablets to achieve their required dosage. Whether deployment involves air-dropping into disaster zones or stocking shelves for community resilience, ThyroSafe ensures readiness when it matters most.














Reviews
There are no reviews yet.